ArticleClinicoEconomics and outcomes research : CEOR2017

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom.

Madhusubramanian Muthukumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.